Skip to main content
. 2016 Apr 12;16:66. doi: 10.1186/s12872-016-0237-z

Table 1.

Baseline characteristics of patients in the two treatment groups

Losartan+barnidipine Losartan+lercanidipine
N 75 76
Age (years) 60.5 ± 8.9 60.7 ± 8.8
Sex (male/female) 37/38 36/40
BMI (Kg/m2) 28.5 ± 1.3 28.2 ± 1.1
Duration of diabetes (months) 9.3 ± 7.2 9.1 ± 7.1
Duration of hypertension (months) 6.4 ± 3.6 6.3 ± 3.5
eGFR (ml/min/1.73 m2) 84.1 ± 8.5 82.5 ± 7.6

Data are means ± SD

BMI body mass index, eGFR estimated glomerular filtration rate